Acarix AB (publ)
Acarix AB (publ) (ACIXF) Stock Competitors & Peer Comparison
See (ACIXF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ACIXF | $0.02 | -19.31% | 26.3M | -2.34 | -$0.01 | N/A |
| SEMHF | $38.64 | +1.76% | 43.2B | 17.33 | $2.23 | +3.02% |
| RSMDF | $17.76 | -6.44% | 25.8B | 17.08 | $1.04 | +1.19% |
| FUJIF | $20.45 | +9.95% | 24.6B | 14.30 | $1.43 | +2.23% |
| RYLPF | $25.50 | -5.30% | 24.3B | 21.61 | $1.18 | +3.90% |
| FUJIY | $9.80 | -3.54% | 23.6B | 13.58 | $0.72 | +3.11% |
| SMMNY | $19.33 | -2.08% | 21.6B | 17.44 | $1.11 | +3.07% |
| CLPBY | $6.13 | -2.23% | 13.9B | 41.00 | $0.15 | +5.80% |
| SONVY | $45.39 | +1.38% | 13.5B | 20.24 | $2.24 | +2.37% |
| SNNUF | $14.95 | +0.00% | 12.8B | 20.76 | $0.72 | +2.60% |
Stock Comparison
ACIXF vs SEMHF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, SEMHF has a market cap of 43.2B. Regarding current trading prices, ACIXF is priced at $0.02, while SEMHF trades at $38.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas SEMHF's P/E ratio is 17.33. In terms of profitability, ACIXF's ROE is -1.04%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, ACIXF is more volatile compared to SEMHF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check SEMHF's competition here
ACIXF vs RSMDF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, RSMDF has a market cap of 25.8B. Regarding current trading prices, ACIXF is priced at $0.02, while RSMDF trades at $17.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas RSMDF's P/E ratio is 17.08. In terms of profitability, ACIXF's ROE is -1.04%, compared to RSMDF's ROE of +0.24%. Regarding short-term risk, ACIXF is more volatile compared to RSMDF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check RSMDF's competition here
ACIXF vs FUJIF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, FUJIF has a market cap of 24.6B. Regarding current trading prices, ACIXF is priced at $0.02, while FUJIF trades at $20.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas FUJIF's P/E ratio is 14.30. In terms of profitability, ACIXF's ROE is -1.04%, compared to FUJIF's ROE of +0.10%. Regarding short-term risk, ACIXF is more volatile compared to FUJIF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check FUJIF's competition here
ACIXF vs RYLPF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, RYLPF has a market cap of 24.3B. Regarding current trading prices, ACIXF is priced at $0.02, while RYLPF trades at $25.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas RYLPF's P/E ratio is 21.61. In terms of profitability, ACIXF's ROE is -1.04%, compared to RYLPF's ROE of +0.09%. Regarding short-term risk, ACIXF is more volatile compared to RYLPF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check RYLPF's competition here
ACIXF vs FUJIY Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, FUJIY has a market cap of 23.6B. Regarding current trading prices, ACIXF is priced at $0.02, while FUJIY trades at $9.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas FUJIY's P/E ratio is 13.58. In terms of profitability, ACIXF's ROE is -1.04%, compared to FUJIY's ROE of +0.08%. Regarding short-term risk, ACIXF is more volatile compared to FUJIY. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check FUJIY's competition here
ACIXF vs SMMNY Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, SMMNY has a market cap of 21.6B. Regarding current trading prices, ACIXF is priced at $0.02, while SMMNY trades at $19.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas SMMNY's P/E ratio is 17.44. In terms of profitability, ACIXF's ROE is -1.04%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, ACIXF is more volatile compared to SMMNY. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check SMMNY's competition here
ACIXF vs CLPBY Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, CLPBY has a market cap of 13.9B. Regarding current trading prices, ACIXF is priced at $0.02, while CLPBY trades at $6.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas CLPBY's P/E ratio is 41.00. In terms of profitability, ACIXF's ROE is -1.04%, compared to CLPBY's ROE of +0.14%. Regarding short-term risk, ACIXF is more volatile compared to CLPBY. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check CLPBY's competition here
ACIXF vs SONVY Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, SONVY has a market cap of 13.5B. Regarding current trading prices, ACIXF is priced at $0.02, while SONVY trades at $45.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas SONVY's P/E ratio is 20.24. In terms of profitability, ACIXF's ROE is -1.04%, compared to SONVY's ROE of +0.20%. Regarding short-term risk, ACIXF is more volatile compared to SONVY. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check SONVY's competition here
ACIXF vs SNNUF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, SNNUF has a market cap of 12.8B. Regarding current trading prices, ACIXF is priced at $0.02, while SNNUF trades at $14.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas SNNUF's P/E ratio is 20.76. In terms of profitability, ACIXF's ROE is -1.04%, compared to SNNUF's ROE of +0.12%. Regarding short-term risk, ACIXF is more volatile compared to SNNUF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check SNNUF's competition here
ACIXF vs SONVF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, SONVF has a market cap of 12.8B. Regarding current trading prices, ACIXF is priced at $0.02, while SONVF trades at $213.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas SONVF's P/E ratio is 19.14. In terms of profitability, ACIXF's ROE is -1.04%, compared to SONVF's ROE of +0.20%. Regarding short-term risk, ACIXF is more volatile compared to SONVF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check SONVF's competition here
ACIXF vs CLPBF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, CLPBF has a market cap of 12.5B. Regarding current trading prices, ACIXF is priced at $0.02, while CLPBF trades at $60.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas CLPBF's P/E ratio is 41.07. In terms of profitability, ACIXF's ROE is -1.04%, compared to CLPBF's ROE of +0.14%. Regarding short-term risk, ACIXF is more volatile compared to CLPBF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check CLPBF's competition here
ACIXF vs OCPNF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, OCPNF has a market cap of 11.3B. Regarding current trading prices, ACIXF is priced at $0.02, while OCPNF trades at $10.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas OCPNF's P/E ratio is 26.23. In terms of profitability, ACIXF's ROE is -1.04%, compared to OCPNF's ROE of +0.09%. Regarding short-term risk, ACIXF is more volatile compared to OCPNF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check OCPNF's competition here
ACIXF vs WILLF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, WILLF has a market cap of 7.8B. Regarding current trading prices, ACIXF is priced at $0.02, while WILLF trades at $36.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas WILLF's P/E ratio is 20.88. In terms of profitability, ACIXF's ROE is -1.04%, compared to WILLF's ROE of +0.16%. Regarding short-term risk, ACIXF is more volatile compared to WILLF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check WILLF's competition here
ACIXF vs WILYY Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, WILYY has a market cap of 7.6B. Regarding current trading prices, ACIXF is priced at $0.02, while WILYY trades at $18.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas WILYY's P/E ratio is 20.51. In terms of profitability, ACIXF's ROE is -1.04%, compared to WILYY's ROE of +0.16%. Regarding short-term risk, ACIXF is more volatile compared to WILYY. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check WILYY's competition here
ACIXF vs GNGBY Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, GNGBY has a market cap of 5.4B. Regarding current trading prices, ACIXF is priced at $0.02, while GNGBY trades at $19.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas GNGBY's P/E ratio is 21.26. In terms of profitability, ACIXF's ROE is -1.04%, compared to GNGBY's ROE of +0.08%. Regarding short-term risk, ACIXF is more volatile compared to GNGBY. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check GNGBY's competition here
ACIXF vs GNGBF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, GNGBF has a market cap of 5.1B. Regarding current trading prices, ACIXF is priced at $0.02, while GNGBF trades at $20.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas GNGBF's P/E ratio is 21.33. In terms of profitability, ACIXF's ROE is -1.04%, compared to GNGBF's ROE of +0.08%. Regarding short-term risk, ACIXF is more volatile compared to GNGBF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check GNGBF's competition here
ACIXF vs CHEOF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, CHEOF has a market cap of 4.9B. Regarding current trading prices, ACIXF is priced at $0.02, while CHEOF trades at $74.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas CHEOF's P/E ratio is 19.29. In terms of profitability, ACIXF's ROE is -1.04%, compared to CHEOF's ROE of +0.18%. Regarding short-term risk, ACIXF is more volatile compared to CHEOF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check CHEOF's competition here
ACIXF vs YPHDF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, YPHDF has a market cap of 4.8B. Regarding current trading prices, ACIXF is priced at $0.02, while YPHDF trades at $354.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas YPHDF's P/E ratio is 19.49. In terms of profitability, ACIXF's ROE is -1.04%, compared to YPHDF's ROE of +0.27%. Regarding short-term risk, ACIXF is more volatile compared to YPHDF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check YPHDF's competition here
ACIXF vs CHEOY Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, CHEOY has a market cap of 4.5B. Regarding current trading prices, ACIXF is priced at $0.02, while CHEOY trades at $34.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas CHEOY's P/E ratio is 18.03. In terms of profitability, ACIXF's ROE is -1.04%, compared to CHEOY's ROE of +0.18%. Regarding short-term risk, ACIXF is more volatile compared to CHEOY. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check CHEOY's competition here
ACIXF vs AMBFF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, AMBFF has a market cap of 3.6B. Regarding current trading prices, ACIXF is priced at $0.02, while AMBFF trades at $13.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas AMBFF's P/E ratio is 48.75. In terms of profitability, ACIXF's ROE is -1.04%, compared to AMBFF's ROE of +0.08%. Regarding short-term risk, ACIXF is more volatile compared to AMBFF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check AMBFF's competition here
ACIXF vs NHNKY Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, NHNKY has a market cap of 3B. Regarding current trading prices, ACIXF is priced at $0.02, while NHNKY trades at $9.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas NHNKY's P/E ratio is 16.32. In terms of profitability, ACIXF's ROE is -1.04%, compared to NHNKY's ROE of +0.07%. Regarding short-term risk, ACIXF is more volatile compared to NHNKY. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check NHNKY's competition here
ACIXF vs AMFPF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, AMFPF has a market cap of 2.8B. Regarding current trading prices, ACIXF is priced at $0.02, while AMFPF trades at $12.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas AMFPF's P/E ratio is 35.03. In terms of profitability, ACIXF's ROE is -1.04%, compared to AMFPF's ROE of +0.07%. Regarding short-term risk, ACIXF is more volatile compared to AMFPF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check AMFPF's competition here
ACIXF vs AMBBY Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, AMBBY has a market cap of 2.5B. Regarding current trading prices, ACIXF is priced at $0.02, while AMBBY trades at $9.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas AMBBY's P/E ratio is 34.20. In terms of profitability, ACIXF's ROE is -1.04%, compared to AMBBY's ROE of +0.08%. Regarding short-term risk, ACIXF is more volatile compared to AMBBY. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check AMBBY's competition here
ACIXF vs NHNKF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, NHNKF has a market cap of 2.4B. Regarding current trading prices, ACIXF is priced at $0.02, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, ACIXF's ROE is -1.04%, compared to NHNKF's ROE of +0.07%. Regarding short-term risk, ACIXF is more volatile compared to NHNKF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check NHNKF's competition here
ACIXF vs MCRPF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, MCRPF has a market cap of 2.2B. Regarding current trading prices, ACIXF is priced at $0.02, while MCRPF trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas MCRPF's P/E ratio is -12.67. In terms of profitability, ACIXF's ROE is -1.04%, compared to MCRPF's ROE of +0.06%. Regarding short-term risk, ACIXF is more volatile compared to MCRPF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check MCRPF's competition here
ACIXF vs GGNDF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, GGNDF has a market cap of 2.1B. Regarding current trading prices, ACIXF is priced at $0.02, while GGNDF trades at $14.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas GGNDF's P/E ratio is 52.14. In terms of profitability, ACIXF's ROE is -1.04%, compared to GGNDF's ROE of -0.04%. Regarding short-term risk, ACIXF is more volatile compared to GGNDF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check GGNDF's competition here
ACIXF vs GNNDY Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, GNNDY has a market cap of 2.1B. Regarding current trading prices, ACIXF is priced at $0.02, while GNNDY trades at $43.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas GNNDY's P/E ratio is 51.11. In terms of profitability, ACIXF's ROE is -1.04%, compared to GNNDY's ROE of -0.04%. Regarding short-term risk, ACIXF is more volatile compared to GNNDY. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check GNNDY's competition here
ACIXF vs DRWKF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, DRWKF has a market cap of 2.1B. Regarding current trading prices, ACIXF is priced at $0.02, while DRWKF trades at $111.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas DRWKF's P/E ratio is 11.65. In terms of profitability, ACIXF's ROE is -1.04%, compared to DRWKF's ROE of +0.10%. Regarding short-term risk, ACIXF is more volatile compared to DRWKF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check DRWKF's competition here
ACIXF vs OSSFF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, OSSFF has a market cap of 1.8B. Regarding current trading prices, ACIXF is priced at $0.02, while OSSFF trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas OSSFF's P/E ratio is 20.75. In terms of profitability, ACIXF's ROE is -1.04%, compared to OSSFF's ROE of +0.10%. Regarding short-term risk, ACIXF is more volatile compared to OSSFF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check OSSFF's competition here
ACIXF vs DWRKF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, ACIXF is priced at $0.02, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, ACIXF's ROE is -1.04%, compared to DWRKF's ROE of N/A. Regarding short-term risk, ACIXF is more volatile compared to DWRKF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check DWRKF's competition here
ACIXF vs MEDGF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, ACIXF is priced at $0.02, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, ACIXF's ROE is -1.04%, compared to MEDGF's ROE of +0.22%. Regarding short-term risk, ACIXF is more volatile compared to MEDGF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check MEDGF's competition here
ACIXF vs BOEUF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, BOEUF has a market cap of 1.7B. Regarding current trading prices, ACIXF is priced at $0.02, while BOEUF trades at $25.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas BOEUF's P/E ratio is 83.83. In terms of profitability, ACIXF's ROE is -1.04%, compared to BOEUF's ROE of +0.22%. Regarding short-term risk, ACIXF is more volatile compared to BOEUF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check BOEUF's competition here
ACIXF vs OSSUY Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, OSSUY has a market cap of 1.6B. Regarding current trading prices, ACIXF is priced at $0.02, while OSSUY trades at $3.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas OSSUY's P/E ratio is 19.08. In terms of profitability, ACIXF's ROE is -1.04%, compared to OSSUY's ROE of +0.10%. Regarding short-term risk, ACIXF is more volatile compared to OSSUY. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check OSSUY's competition here
ACIXF vs DGWPF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, DGWPF has a market cap of 1.6B. Regarding current trading prices, ACIXF is priced at $0.02, while DGWPF trades at $83.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas DGWPF's P/E ratio is 8.65. In terms of profitability, ACIXF's ROE is -1.04%, compared to DGWPF's ROE of +0.10%. Regarding short-term risk, ACIXF is more volatile compared to DGWPF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check DGWPF's competition here
ACIXF vs VTRLY Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, VTRLY has a market cap of 1.5B. Regarding current trading prices, ACIXF is priced at $0.02, while VTRLY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas VTRLY's P/E ratio is -2.74. In terms of profitability, ACIXF's ROE is -1.04%, compared to VTRLY's ROE of -0.47%. Regarding short-term risk, ACIXF is more volatile compared to VTRLY. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check VTRLY's competition here
ACIXF vs FDMDF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, FDMDF has a market cap of 1.5B. Regarding current trading prices, ACIXF is priced at $0.02, while FDMDF trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas FDMDF's P/E ratio is -8.62. In terms of profitability, ACIXF's ROE is -1.04%, compared to FDMDF's ROE of -9.21%. Regarding short-term risk, ACIXF is more volatile compared to FDMDF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check FDMDF's competition here
ACIXF vs MDRSF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, MDRSF has a market cap of 1.4B. Regarding current trading prices, ACIXF is priced at $0.02, while MDRSF trades at $115.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas MDRSF's P/E ratio is 133.72. In terms of profitability, ACIXF's ROE is -1.04%, compared to MDRSF's ROE of +0.03%. Regarding short-term risk, ACIXF is more volatile compared to MDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check MDRSF's competition here
ACIXF vs ELEAF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, ELEAF has a market cap of 1.3B. Regarding current trading prices, ACIXF is priced at $0.02, while ELEAF trades at $15.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas ELEAF's P/E ratio is 21.83. In terms of profitability, ACIXF's ROE is -1.04%, compared to ELEAF's ROE of +0.16%. Regarding short-term risk, ACIXF is more volatile compared to ELEAF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check ELEAF's competition here
ACIXF vs LFTSF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, LFTSF has a market cap of 1B. Regarding current trading prices, ACIXF is priced at $0.02, while LFTSF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas LFTSF's P/E ratio is 23.35. In terms of profitability, ACIXF's ROE is -1.04%, compared to LFTSF's ROE of +0.02%. Regarding short-term risk, ACIXF is more volatile compared to LFTSF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check LFTSF's competition here
ACIXF vs XVIPF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, XVIPF has a market cap of 718.5M. Regarding current trading prices, ACIXF is priced at $0.02, while XVIPF trades at $22.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas XVIPF's P/E ratio is 91.24. In terms of profitability, ACIXF's ROE is -1.04%, compared to XVIPF's ROE of +0.03%. Regarding short-term risk, ACIXF is more volatile compared to XVIPF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check XVIPF's competition here
ACIXF vs BRSYF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, BRSYF has a market cap of 674.2M. Regarding current trading prices, ACIXF is priced at $0.02, while BRSYF trades at $16.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas BRSYF's P/E ratio is 93.56. In terms of profitability, ACIXF's ROE is -1.04%, compared to BRSYF's ROE of +0.11%. Regarding short-term risk, ACIXF is more volatile compared to BRSYF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check BRSYF's competition here
ACIXF vs CALZF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, CALZF has a market cap of 593.7M. Regarding current trading prices, ACIXF is priced at $0.02, while CALZF trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas CALZF's P/E ratio is 85.94. In terms of profitability, ACIXF's ROE is -1.04%, compared to CALZF's ROE of +0.12%. Regarding short-term risk, ACIXF is more volatile compared to CALZF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check CALZF's competition here
ACIXF vs IOBCF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, IOBCF has a market cap of 501.5M. Regarding current trading prices, ACIXF is priced at $0.02, while IOBCF trades at $17.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas IOBCF's P/E ratio is 34.90. In terms of profitability, ACIXF's ROE is -1.04%, compared to IOBCF's ROE of +0.10%. Regarding short-term risk, ACIXF is more volatile compared to IOBCF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check IOBCF's competition here
ACIXF vs AVMR Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, ACIXF is priced at $0.02, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas AVMR's P/E ratio is -18.34. In terms of profitability, ACIXF's ROE is -1.04%, compared to AVMR's ROE of -0.23%. Regarding short-term risk, ACIXF is more volatile compared to AVMR. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check AVMR's competition here
ACIXF vs DMTRF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, DMTRF has a market cap of 476M. Regarding current trading prices, ACIXF is priced at $0.02, while DMTRF trades at $3.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas DMTRF's P/E ratio is -198.00. In terms of profitability, ACIXF's ROE is -1.04%, compared to DMTRF's ROE of +0.36%. Regarding short-term risk, ACIXF is less volatile compared to DMTRF. This indicates potentially lower risk in terms of short-term price fluctuations for ACIXF.Check DMTRF's competition here
ACIXF vs HYBT Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, ACIXF is priced at $0.02, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas HYBT's P/E ratio is N/A. In terms of profitability, ACIXF's ROE is -1.04%, compared to HYBT's ROE of +0.02%. Regarding short-term risk, ACIXF is more volatile compared to HYBT. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check HYBT's competition here
ACIXF vs CYBQY Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, CYBQY has a market cap of 338.8M. Regarding current trading prices, ACIXF is priced at $0.02, while CYBQY trades at $1.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas CYBQY's P/E ratio is -190.00. In terms of profitability, ACIXF's ROE is -1.04%, compared to CYBQY's ROE of -0.00%. Regarding short-term risk, ACIXF is more volatile compared to CYBQY. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check CYBQY's competition here
ACIXF vs CSSPF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, CSSPF has a market cap of 336.4M. Regarding current trading prices, ACIXF is priced at $0.02, while CSSPF trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas CSSPF's P/E ratio is 39.98. In terms of profitability, ACIXF's ROE is -1.04%, compared to CSSPF's ROE of +0.10%. Regarding short-term risk, ACIXF is more volatile compared to CSSPF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check CSSPF's competition here
ACIXF vs EBRCZ Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, EBRCZ has a market cap of 329.8M. Regarding current trading prices, ACIXF is priced at $0.02, while EBRCZ trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas EBRCZ's P/E ratio is -3.69. In terms of profitability, ACIXF's ROE is -1.04%, compared to EBRCZ's ROE of -1.80%. Regarding short-term risk, ACIXF is more volatile compared to EBRCZ. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check EBRCZ's competition here
ACIXF vs CLVSF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, CLVSF has a market cap of 321.8M. Regarding current trading prices, ACIXF is priced at $0.02, while CLVSF trades at $13.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas CLVSF's P/E ratio is 22.11. In terms of profitability, ACIXF's ROE is -1.04%, compared to CLVSF's ROE of +0.15%. Regarding short-term risk, ACIXF is more volatile compared to CLVSF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check CLVSF's competition here
ACIXF vs CYBQF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, CYBQF has a market cap of 246.8M. Regarding current trading prices, ACIXF is priced at $0.02, while CYBQF trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas CYBQF's P/E ratio is -185.00. In terms of profitability, ACIXF's ROE is -1.04%, compared to CYBQF's ROE of -0.00%. Regarding short-term risk, ACIXF is more volatile compared to CYBQF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check CYBQF's competition here
ACIXF vs HTLZF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, ACIXF is priced at $0.02, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, ACIXF's ROE is -1.04%, compared to HTLZF's ROE of -0.01%. Regarding short-term risk, ACIXF is more volatile compared to HTLZF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check HTLZF's competition here
ACIXF vs IMPZY Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, IMPZY has a market cap of 229.3M. Regarding current trading prices, ACIXF is priced at $0.02, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, ACIXF's ROE is -1.04%, compared to IMPZY's ROE of +8.77%. Regarding short-term risk, ACIXF is more volatile compared to IMPZY. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check IMPZY's competition here
ACIXF vs XVIPY Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, XVIPY has a market cap of 206M. Regarding current trading prices, ACIXF is priced at $0.02, while XVIPY trades at $6.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas XVIPY's P/E ratio is N/A. In terms of profitability, ACIXF's ROE is -1.04%, compared to XVIPY's ROE of +0.01%. Regarding short-term risk, ACIXF is more volatile compared to XVIPY. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check XVIPY's competition here
ACIXF vs VMTHF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, VMTHF has a market cap of 186.1M. Regarding current trading prices, ACIXF is priced at $0.02, while VMTHF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas VMTHF's P/E ratio is -3.01. In terms of profitability, ACIXF's ROE is -1.04%, compared to VMTHF's ROE of -0.21%. Regarding short-term risk, ACIXF is more volatile compared to VMTHF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check VMTHF's competition here
ACIXF vs BCCOY Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, BCCOY has a market cap of 183.5M. Regarding current trading prices, ACIXF is priced at $0.02, while BCCOY trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas BCCOY's P/E ratio is -1.14. In terms of profitability, ACIXF's ROE is -1.04%, compared to BCCOY's ROE of -0.51%. Regarding short-term risk, ACIXF is more volatile compared to BCCOY. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check BCCOY's competition here
ACIXF vs DTXMF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, DTXMF has a market cap of 180.6M. Regarding current trading prices, ACIXF is priced at $0.02, while DTXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas DTXMF's P/E ratio is -9.52. In terms of profitability, ACIXF's ROE is -1.04%, compared to DTXMF's ROE of -0.74%. Regarding short-term risk, ACIXF is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for ACIXF.Check DTXMF's competition here
ACIXF vs CLLKF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, CLLKF has a market cap of 157.5M. Regarding current trading prices, ACIXF is priced at $0.02, while CLLKF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas CLLKF's P/E ratio is -1.00. In terms of profitability, ACIXF's ROE is -1.04%, compared to CLLKF's ROE of -0.52%. Regarding short-term risk, ACIXF is more volatile compared to CLLKF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check CLLKF's competition here
ACIXF vs EKDHF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, EKDHF has a market cap of 150.5M. Regarding current trading prices, ACIXF is priced at $0.02, while EKDHF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas EKDHF's P/E ratio is 34.96. In terms of profitability, ACIXF's ROE is -1.04%, compared to EKDHF's ROE of +0.03%. Regarding short-term risk, ACIXF is more volatile compared to EKDHF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check EKDHF's competition here
ACIXF vs PXMBF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, PXMBF has a market cap of 149.9M. Regarding current trading prices, ACIXF is priced at $0.02, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, ACIXF's ROE is -1.04%, compared to PXMBF's ROE of -0.04%. Regarding short-term risk, ACIXF is more volatile compared to PXMBF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check PXMBF's competition here
ACIXF vs EAPIF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, EAPIF has a market cap of 147.5M. Regarding current trading prices, ACIXF is priced at $0.02, while EAPIF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas EAPIF's P/E ratio is -0.59. In terms of profitability, ACIXF's ROE is -1.04%, compared to EAPIF's ROE of -0.24%. Regarding short-term risk, ACIXF is more volatile compared to EAPIF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check EAPIF's competition here
ACIXF vs AMEUF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, ACIXF is priced at $0.02, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, ACIXF's ROE is -1.04%, compared to AMEUF's ROE of -1.90%. Regarding short-term risk, ACIXF is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for ACIXF.Check AMEUF's competition here
ACIXF vs SOMNF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, SOMNF has a market cap of 98.6M. Regarding current trading prices, ACIXF is priced at $0.02, while SOMNF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas SOMNF's P/E ratio is -45.00. In terms of profitability, ACIXF's ROE is -1.04%, compared to SOMNF's ROE of -0.05%. Regarding short-term risk, ACIXF is more volatile compared to SOMNF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check SOMNF's competition here
ACIXF vs JMDMF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, JMDMF has a market cap of 94.1M. Regarding current trading prices, ACIXF is priced at $0.02, while JMDMF trades at $3.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas JMDMF's P/E ratio is -13.68. In terms of profitability, ACIXF's ROE is -1.04%, compared to JMDMF's ROE of N/A. Regarding short-term risk, ACIXF is less volatile compared to JMDMF. This indicates potentially lower risk in terms of short-term price fluctuations for ACIXF.Check JMDMF's competition here
ACIXF vs RSHUF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, ACIXF is priced at $0.02, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, ACIXF's ROE is -1.04%, compared to RSHUF's ROE of -4.12%. Regarding short-term risk, ACIXF is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for ACIXF.Check RSHUF's competition here
ACIXF vs AVHHL Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, AVHHL has a market cap of 90.1M. Regarding current trading prices, ACIXF is priced at $0.02, while AVHHL trades at $0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas AVHHL's P/E ratio is -2.07. In terms of profitability, ACIXF's ROE is -1.04%, compared to AVHHL's ROE of +3.05%. Regarding short-term risk, ACIXF is more volatile compared to AVHHL. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check AVHHL's competition here
ACIXF vs CKMTF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, ACIXF is priced at $0.02, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, ACIXF's ROE is -1.04%, compared to CKMTF's ROE of +2.58%. Regarding short-term risk, ACIXF is more volatile compared to CKMTF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check CKMTF's competition here
ACIXF vs SNZZF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, SNZZF has a market cap of 75M. Regarding current trading prices, ACIXF is priced at $0.02, while SNZZF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas SNZZF's P/E ratio is -5.30. In terms of profitability, ACIXF's ROE is -1.04%, compared to SNZZF's ROE of -0.38%. Regarding short-term risk, ACIXF is more volatile compared to SNZZF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check SNZZF's competition here
ACIXF vs BLOZF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, BLOZF has a market cap of 62.5M. Regarding current trading prices, ACIXF is priced at $0.02, while BLOZF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas BLOZF's P/E ratio is -12.75. In terms of profitability, ACIXF's ROE is -1.04%, compared to BLOZF's ROE of -3.03%. Regarding short-term risk, ACIXF is more volatile compared to BLOZF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check BLOZF's competition here
ACIXF vs TLTFF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, TLTFF has a market cap of 51.9M. Regarding current trading prices, ACIXF is priced at $0.02, while TLTFF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas TLTFF's P/E ratio is -18.83. In terms of profitability, ACIXF's ROE is -1.04%, compared to TLTFF's ROE of -3.15%. Regarding short-term risk, ACIXF is more volatile compared to TLTFF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check TLTFF's competition here
ACIXF vs BRNHF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, BRNHF has a market cap of 42.1M. Regarding current trading prices, ACIXF is priced at $0.02, while BRNHF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas BRNHF's P/E ratio is -1.33. In terms of profitability, ACIXF's ROE is -1.04%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, ACIXF is more volatile compared to BRNHF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check BRNHF's competition here
ACIXF vs NVYTF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, NVYTF has a market cap of 34.8M. Regarding current trading prices, ACIXF is priced at $0.02, while NVYTF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas NVYTF's P/E ratio is -0.86. In terms of profitability, ACIXF's ROE is -1.04%, compared to NVYTF's ROE of -1.25%. Regarding short-term risk, ACIXF is more volatile compared to NVYTF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check NVYTF's competition here
ACIXF vs RDGL Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, RDGL has a market cap of 31.9M. Regarding current trading prices, ACIXF is priced at $0.02, while RDGL trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas RDGL's P/E ratio is -6.60. In terms of profitability, ACIXF's ROE is -1.04%, compared to RDGL's ROE of -1.48%. Regarding short-term risk, ACIXF is more volatile compared to RDGL. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check RDGL's competition here
ACIXF vs POSC Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, POSC has a market cap of 27.3M. Regarding current trading prices, ACIXF is priced at $0.02, while POSC trades at $1.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas POSC's P/E ratio is -5.63. In terms of profitability, ACIXF's ROE is -1.04%, compared to POSC's ROE of -4.69%. Regarding short-term risk, ACIXF is more volatile compared to POSC. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check POSC's competition here
ACIXF vs MKEAF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, MKEAF has a market cap of 25.9M. Regarding current trading prices, ACIXF is priced at $0.02, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, ACIXF's ROE is -1.04%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, ACIXF is more volatile compared to MKEAF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check MKEAF's competition here
ACIXF vs TCLIF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, TCLIF has a market cap of 25.1M. Regarding current trading prices, ACIXF is priced at $0.02, while TCLIF trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas TCLIF's P/E ratio is -4.84. In terms of profitability, ACIXF's ROE is -1.04%, compared to TCLIF's ROE of +2.39%. Regarding short-term risk, ACIXF is less volatile compared to TCLIF. This indicates potentially lower risk in terms of short-term price fluctuations for ACIXF.Check TCLIF's competition here
ACIXF vs KBBTF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, ACIXF is priced at $0.02, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, ACIXF's ROE is -1.04%, compared to KBBTF's ROE of N/A. Regarding short-term risk, ACIXF is more volatile compared to KBBTF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check KBBTF's competition here
ACIXF vs PYNKF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, PYNKF has a market cap of 23.1M. Regarding current trading prices, ACIXF is priced at $0.02, while PYNKF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas PYNKF's P/E ratio is 3.67. In terms of profitability, ACIXF's ROE is -1.04%, compared to PYNKF's ROE of -2.78%. Regarding short-term risk, ACIXF is more volatile compared to PYNKF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check PYNKF's competition here
ACIXF vs EMITF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, EMITF has a market cap of 21.3M. Regarding current trading prices, ACIXF is priced at $0.02, while EMITF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas EMITF's P/E ratio is -7.62. In terms of profitability, ACIXF's ROE is -1.04%, compared to EMITF's ROE of -0.07%. Regarding short-term risk, ACIXF is more volatile compared to EMITF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check EMITF's competition here
ACIXF vs VPTDF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, VPTDF has a market cap of 21.2M. Regarding current trading prices, ACIXF is priced at $0.02, while VPTDF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas VPTDF's P/E ratio is -11.30. In terms of profitability, ACIXF's ROE is -1.04%, compared to VPTDF's ROE of +0.78%. Regarding short-term risk, ACIXF is more volatile compared to VPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check VPTDF's competition here
ACIXF vs DIZTF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, DIZTF has a market cap of 18M. Regarding current trading prices, ACIXF is priced at $0.02, while DIZTF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas DIZTF's P/E ratio is -11.16. In terms of profitability, ACIXF's ROE is -1.04%, compared to DIZTF's ROE of -0.52%. Regarding short-term risk, ACIXF is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for ACIXF.Check DIZTF's competition here
ACIXF vs GTHP Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, GTHP has a market cap of 15.3M. Regarding current trading prices, ACIXF is priced at $0.02, while GTHP trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas GTHP's P/E ratio is -5.00. In terms of profitability, ACIXF's ROE is -1.04%, compared to GTHP's ROE of +0.96%. Regarding short-term risk, ACIXF is more volatile compared to GTHP. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check GTHP's competition here
ACIXF vs MDXHF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, MDXHF has a market cap of 14.4M. Regarding current trading prices, ACIXF is priced at $0.02, while MDXHF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas MDXHF's P/E ratio is -4.40. In terms of profitability, ACIXF's ROE is -1.04%, compared to MDXHF's ROE of +0.66%. Regarding short-term risk, ACIXF is more volatile compared to MDXHF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check MDXHF's competition here
ACIXF vs IPDQF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, IPDQF has a market cap of 14.3M. Regarding current trading prices, ACIXF is priced at $0.02, while IPDQF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas IPDQF's P/E ratio is -0.70. In terms of profitability, ACIXF's ROE is -1.04%, compared to IPDQF's ROE of -1.65%. Regarding short-term risk, ACIXF is more volatile compared to IPDQF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check IPDQF's competition here
ACIXF vs ASAPF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, ASAPF has a market cap of 14M. Regarding current trading prices, ACIXF is priced at $0.02, while ASAPF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas ASAPF's P/E ratio is -17.90. In terms of profitability, ACIXF's ROE is -1.04%, compared to ASAPF's ROE of -0.19%. Regarding short-term risk, ACIXF is more volatile compared to ASAPF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check ASAPF's competition here
ACIXF vs TMDIF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, ACIXF is priced at $0.02, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, ACIXF's ROE is -1.04%, compared to TMDIF's ROE of +8.70%. Regarding short-term risk, ACIXF is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for ACIXF.Check TMDIF's competition here
ACIXF vs ATBPF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, ACIXF is priced at $0.02, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, ACIXF's ROE is -1.04%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, ACIXF is more volatile compared to ATBPF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check ATBPF's competition here
ACIXF vs LXXGF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, ACIXF is priced at $0.02, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, ACIXF's ROE is -1.04%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, ACIXF is more volatile compared to LXXGF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check LXXGF's competition here
ACIXF vs ALRTF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, ALRTF has a market cap of 9.7M. Regarding current trading prices, ACIXF is priced at $0.02, while ALRTF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas ALRTF's P/E ratio is -0.37. In terms of profitability, ACIXF's ROE is -1.04%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, ACIXF is more volatile compared to ALRTF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check ALRTF's competition here
ACIXF vs BIEL Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, BIEL has a market cap of 8.1M. Regarding current trading prices, ACIXF is priced at $0.02, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas BIEL's P/E ratio is N/A. In terms of profitability, ACIXF's ROE is -1.04%, compared to BIEL's ROE of +0.05%. Regarding short-term risk, ACIXF is less volatile compared to BIEL. This indicates potentially lower risk in terms of short-term price fluctuations for ACIXF.Check BIEL's competition here
ACIXF vs PLLWF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, PLLWF has a market cap of 8M. Regarding current trading prices, ACIXF is priced at $0.02, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas PLLWF's P/E ratio is -0.66. In terms of profitability, ACIXF's ROE is -1.04%, compared to PLLWF's ROE of -0.99%. Regarding short-term risk, ACIXF is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for ACIXF.Check PLLWF's competition here
ACIXF vs PMEDF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, PMEDF has a market cap of 6.8M. Regarding current trading prices, ACIXF is priced at $0.02, while PMEDF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas PMEDF's P/E ratio is -3.30. In terms of profitability, ACIXF's ROE is -1.04%, compared to PMEDF's ROE of +1.24%. Regarding short-term risk, ACIXF is more volatile compared to PMEDF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check PMEDF's competition here
ACIXF vs QLIS Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, ACIXF is priced at $0.02, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas QLIS's P/E ratio is 2.22. In terms of profitability, ACIXF's ROE is -1.04%, compared to QLIS's ROE of -0.77%. Regarding short-term risk, ACIXF is more volatile compared to QLIS. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check QLIS's competition here
ACIXF vs RHNMF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, ACIXF is priced at $0.02, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, ACIXF's ROE is -1.04%, compared to RHNMF's ROE of +15.91%. Regarding short-term risk, ACIXF is more volatile compared to RHNMF. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check RHNMF's competition here
ACIXF vs ADMT Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, ADMT has a market cap of 5.4M. Regarding current trading prices, ACIXF is priced at $0.02, while ADMT trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas ADMT's P/E ratio is -8.00. In terms of profitability, ACIXF's ROE is -1.04%, compared to ADMT's ROE of -0.01%. Regarding short-term risk, ACIXF is more volatile compared to ADMT. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check ADMT's competition here
ACIXF vs USAQ Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, USAQ has a market cap of 5.1M. Regarding current trading prices, ACIXF is priced at $0.02, while USAQ trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas USAQ's P/E ratio is 22.50. In terms of profitability, ACIXF's ROE is -1.04%, compared to USAQ's ROE of +0.92%. Regarding short-term risk, ACIXF is more volatile compared to USAQ. This indicates potentially higher risk in terms of short-term price fluctuations for ACIXF.Check USAQ's competition here
ACIXF vs RMSL Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, RMSL has a market cap of 4.6M. Regarding current trading prices, ACIXF is priced at $0.02, while RMSL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas RMSL's P/E ratio is 0.27. In terms of profitability, ACIXF's ROE is -1.04%, compared to RMSL's ROE of -17961324.55%. Regarding short-term risk, ACIXF is less volatile compared to RMSL. This indicates potentially lower risk in terms of short-term price fluctuations for ACIXF.Check RMSL's competition here
ACIXF vs ELXMF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, ELXMF has a market cap of 4.1M. Regarding current trading prices, ACIXF is priced at $0.02, while ELXMF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas ELXMF's P/E ratio is -0.72. In terms of profitability, ACIXF's ROE is -1.04%, compared to ELXMF's ROE of -0.40%. Regarding short-term risk, ACIXF is less volatile compared to ELXMF. This indicates potentially lower risk in terms of short-term price fluctuations for ACIXF.Check ELXMF's competition here
ACIXF vs NGMDF Comparison May 2026
ACIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIXF stands at 26.3M. In comparison, NGMDF has a market cap of 3.7M. Regarding current trading prices, ACIXF is priced at $0.02, while NGMDF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIXF currently has a P/E ratio of -2.34, whereas NGMDF's P/E ratio is -0.55. In terms of profitability, ACIXF's ROE is -1.04%, compared to NGMDF's ROE of +0.94%. Regarding short-term risk, ACIXF is less volatile compared to NGMDF. This indicates potentially lower risk in terms of short-term price fluctuations for ACIXF.Check NGMDF's competition here